| Literature DB >> 25763139 |
Saman Nikeghbalian1, Mohammad Naser Toutouni2, Heshmatollah Salahi3, Mohsen Aliakbarian4, Seyed Ali Malekhosseini3.
Abstract
BACKGROUND: The classic technique of hepatectomy with venovenous bypass may cause a longer anhepatic phase and increase the rate of some complications, such as post-operative renal failure and thromboembolic events. But, in some cases, such as tumors and anatomic difficulties, the surgeon is obligated to use the classic technique even though there is some controversy about the safety of this technique without venovenous bypass in liver transplantation. The aim of this study was to compare the results of using the classic technique without venovenous bypass and the piggyback technique for liver transplantation.Entities:
Keywords: classic technique; liver transplantation; piggyback technique; venovenous bypass
Year: 2014 PMID: 25763139 PMCID: PMC4324279 DOI: 10.14661/2014.741-746
Source DB: PubMed Journal: Electron Physician ISSN: 2008-5842
Causes of liver transplantation and their frequencies in the two groups
| HBV cirrhosis | 38 (22.1) | 6 (10.9) |
| Cryptogenic cirrhosis | 32 (18.6) | 12 (21.8) |
| Autoimmune hepatitis | 32 (18.6) | 9 (16.4) |
| Wilson’s disease | 10 (5.8) | 1 (1.8) |
| HCV cirrhosis | 9 (5.2) | 2 (3.6) |
| PSC | 9 (5.2) | 8 (14.6) |
| HCC | 8 (4.7) | 5 (9.1) |
| Budd-chiari syndrome | 2 (1.2) | 6 (10.9) |
| Other | 32 (18.6) | 6 (10.9) |
Characteristics of the subjects in the study and findings
| Age (yr) | 36.95 ± 15.29 | 40.17 ± 15.7 | NS |
| Gender (M/F) | 108/64 | 40/15 | NS |
| MELD score | 21.34 ± 5.22 | 20.62 ± 7.03 | NS |
| Donor’s age (yr) | 32.58 ± 14.8 | 31.33 ± 12.4 | NS |
| Cold ischemic time (hr) | 8.03 ± 2.82 | 7.89± 2.7 | NS |
| Warm Ischemic Time (min) | 45.07 ± 9.54 | 51.76±8.28 | 0.0 |
| Duration of Operation (min) | 349.51 ± 67.57 | 370.58±79.98 | NS |
| Crystalloid infused Volume (lit) | 3.62 ± 1.7 | 4.4±1.7 | 0.003 |
| Albumin infused Volume (cm3) | 58.17 ± 20.93 | 65.82± 19.4 | 0.017 |
| Packed RBC transfused Volume (unit) | 2.78 ±9.45 | 3.35±3.18 | NS |
| Pre-operation Creatinine (mg/dl) | 1.031 ±1.22 | 0.97± 0.6 | NS |
| Preoperation Bilirubin (mg/dl) | 7.27 ±9.5 | 8.75± 11.25 | NS |
| Creatinine (days 1–7) (patients < 1.5/patients > 1.5) | 123/49 | 37/18 | NS |
| BP Drop (during operation) | NS | ||
| BP (mmHg) (in anhepatic phase) | 61.98 ± 9.6 | 64.24±9.38 | NS |
| ALT (U/L) (1–8 days) | NS | ||
| Creatinine (all patients) (1–7 days vs. pre-operation) | NS | ||
| CRRT use | NS | ||
| In-hospital mortality (%) | 1.75 | 1.81 | NS |
| Hospital stay (day) | 14.6 ± 9.76 | 12.42 ± 4.5 | 0.024 |
| Mortality rate (%) | 8.14 | 5.45 | NS |
| One-year survival rate, % | 92 | 94.4 | NS |
| Bleeding volume before hepatectomy (cm3) | 613.31 ± 628.1 | 1167.27 ± 1098.9 | 0.001 |
| Bleeding volume after hepatectomy (cm3) | 916.53 ± 1138.73 | 1161.82 ± 1103.9 | NS |
| Total bleeding (cm3) | 1529.22 | 2319.45 | 0.010 |
| Urine output (intraoperative) (cm3) | 827.85 | 1001.57 | 0.035 |
NS = Not Significant;
= better in group 1;
= better in group 2
Figure 1.Blood pressure (BP) changes during the phases of the operation
(1: pre-anhepatic, 2: anhepatic, 3: post-anhepatic)
Figure 2.Survival rates in group 1 and group 2